<DOC>
	<DOCNO>NCT01291316</DOCNO>
	<brief_summary>In animal , GABAergic system modulate central sensitisation , key phenomenon pain processing . The development GABAA agonists target subunit GABAA receptor implicate nociception , subunit implicated sedation attractive open new perspective test role GABAergic modulation pain processing human volunteer . The purpose subproject test effect specific α2 α3 agonist spar α1 effect TPA023 human model peripheral central sensitisation correlate pharmacodynamic effect pharmacokinetic compound . The result would contribute clarify potential role α2/α3 agonist spar α1drugs clinical pain condition .</brief_summary>
	<brief_title>GABAergic Modulation Pain Transmission Human : Effect GABAA Agonist Clobazam Peripheral Central Sensitisation</brief_title>
	<detailed_description>Objectives : - To assess effect GABAA agonist clobazam central sensitisation ( change size area secondary hyperalgesia ) healthy volunteer . - To assess effect GABAA agonist clobazam peripheral sensitisation . - To assess effect GABAA agonist clobazam sedation . - To correlate pharmacokinetic clobazam effect ( PK-PD modelling ) - To describe role polymorphism CYP450 2C19 pharmacokinetic dynamic clobazam . Methodology : phase II , exploratory , three arm randomise placebo-controlled , double blind cross-over study healthy volunteer Number patient : 25 Test product , Dose , Route administration : Clobazam,20 mg , oral intake Duration treatment : Single dose administration compound Reference therapy : Clonazepam 1mg , oral intake Tolterodine 1 , 37mg , oral intake Other therapy : Flumazenil 0.2mg , intravenous Efficacy evaluation : 1 . Determination impact clobazam : - size area secondary hyperalgesia induce UVB irradiation skin ( sunburn model ) . The area map electronical Von Frey filament - pain threshold ( heat , static mechanical threshold ) primary secondary area hyperalgesia - nociceptive flexion reflex - tolerance pain threshold ( cold pressor test ) - degree sedation measure saccadic eye movement , digit substation symbol test ( DSST ) numerical rating scale . 2 . Determination concentration-time curve clobazam PK-PD modelling . Statistical Methods : Based result previous study do unit , assess effect association paracetamol ketorolac sunburn model30 , number volunteer require detect 30 % reduction area hyperalgesia 4830 . However choose low intensity UVB irradiation previous study . Using dose irradiation 3 med , number fall 18 , adopt 5 % level statistical significance 80 % power . Taking two result account go 25 volunteer . Data analyse multifactorial analysis variance ( MANOVA ) analysis variance ( ANOVA ) repeat measure In case withdrawal , data obtain used analysis . Data set however complete enrol substitute volunteer .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<mesh_term>Clonazepam</mesh_term>
	<mesh_term>Clobazam</mesh_term>
	<criteria>Male subject , age 18 60 year old Caucasian Type 3 skin phototype Non smoker moderate smoker ( &lt; 10 cigarettes/day ) No clinically abnormal finding history and/or physical examination Presence area secondary hyperalgesia UVB irradiation Any concomitant illness Current past history drug alcohol abuse current intake 3 glass alcohol day 21 glass alcohol per week Psychotropic drug intake last month Sun allergy skin disease Current regular intake drug might affect nociception Paracetamol , NSAIDS short half life permit stop least 48 h UVB session</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>